Latest news
Long-Term OMNIVORE Data Show Durable Treatment-Free Survival After Nivolumab in Advanced RCC - OncLiveOncLive · Thu, 06 Aug 2026 12:18:02 GMTAdvanced Renal Cell Carcinoma: Applying Sequencing Principles in Clinical Practice - Targeted OncologyTargeted Oncology · Thu, 06 Aug 2026 12:16:28 GMTAdvanced Renal Cell Carcinoma: Interpreting Emerging Evidence for Belzutifan-Based Therapies - Targeted OncologyTargeted Oncology · Thu, 06 Aug 2026 12:05:08 GMTPhase I Trial Evaluates Allogeneic CD70-Targeted CAR T-Cell Therapy in Advanced Renal Cell Carcinoma - The ASCO PostThe ASCO Post · Wed, 05 Aug 2026 14:32:11 GMTAdvanced Renal Cell Carcinoma: Incorporating Quality of Life into Treatment Sequencing - Targeted OncologyTargeted Oncology · Thu, 30 Jul 2026 12:14:42 GMTAdvanced Renal Cell Carcinoma: Individualizing Sequencing Based on Disease Characteristics and Patient Factors - Targeted OncologyTargeted Oncology · Thu, 30 Jul 2026 12:09:19 GMTStudy: Casdatifan Demonstrates Durable Tumor Responses in Heavily Pretreated Patients with Advanced Kidney Cancer | Newswise - NewswiseNewswise · Tue, 28 Jul 2026 00:25:00 GMTDarlifarnib Plus Cabozantinib Shows Durable Activity in Advanced RCC - Targeted OncologyTargeted Oncology · Mon, 27 Jul 2026 15:10:16 GMT